Trichuris suis ova therapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 1-3, 2010, Pages

  Bager, Peter ^a   Arnved, John ^b   Rønborg, Steen ^b   Wohlfahrt, Jan ^a   Poulsen, Lars K ^c   Westergaard, Tine ^a   Petersen, Henning Willads ^d   Kristensen, Bjarne ^e   Thamsborg, Stig ^d   Roepstorff, Allan ^d   Kapel, Christian ^d   Melbye, Mads ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b Pulmonology and Allergy Clinic of Copenhagen   (Denmark)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e Thermo Fisher Scientific   (United States)

Author keywords

Allergic rhinitis; allergy; eosinophils; helminth; IgE; parasite; randomized clinical trial; skin prick test; total histamine; Trichuris suis

Indexed keywords

ANTIALLERGIC AGENT; HISTAMINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; PLACEBO; TRICHURIS SUIS OVA; UNCLASSIFIED DRUG;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; EOSINOPHIL COUNT; FEMALE; FLATULENCE; GRASS POLLEN; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NASAL PRURITUS; OUTCOME ASSESSMENT; PARALLEL DESIGN; PRICK TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SNEEZING; TREATMENT OUTCOME; TRICHURIS; TRICHURIS SUIS; UPPER ABDOMINAL PAIN;

EID: 73349085552     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.08.006     Document Type: Article

References (62)

1. Butland B.K., Strachan D.P., Lewis S., Bynner J., Butler N., and Britton J. Investigation into the increase in hay fever and eczema at age 16 observed between the 1958 and 1970 British birth cohorts. BMJ 315 (1997) 717-721
2. Linneberg A., Gislum M., Johansen N., Husemoen L.L., and Jorgensen T. Temporal trends of aeroallergen sensitization over twenty-five years. Clin Exp Allergy 37 (2007) 1137-1142
3. Plaut M., and Valentine M.D. Clinical practice: allergic rhinitis. N Engl J Med 353 (2005) 1934-1944
4. Schnoeller C., Rausch S., Pillai S., Avagyan A., Wittig B.M., Loddenkemper C., et al. A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J Immunol 180 (2008) 4265-4272
5. Hartmann S., Schnoeller C., Dahten A., Avagyan A., Rausch S., Lendner M., et al. Gastrointestinal nematode infection interferes with experimental allergic airway inflammation but not atopic dermatitis. Clin Exp Allergy (2009) Epub ahead of print, June 8
6. Pacifico L.G., Marinho F.A., Fonseca C.T., Barsante M.M., Pinho V., Sales-Junior P.A., et al. Schistosoma mansoni antigens modulate experimental allergic asthma in a murine model: a major role for CD4 + CD25 + Foxp3 + T cells independent of interleukin-10. Infect Immun 77 (2009) 98-107
7. Fenoy I., Giovannoni M., Batalla E., Martin V., Frank F.M., Piazzon I., et al. Toxoplasma gondii infection blocks the development of allergic airway inflammation in BALB/c mice. Clin Exp Immunol 155 (2009) 275-284
8. Dittrich A.M., Erbacher A., Specht S., Diesner F., Krokowski M., Avagyan A., et al. Helminth infection with Litomosoides sigmodontis induces regulatory T cells and inhibits allergic sensitization, airway inflammation, and hyperreactivity in a murine asthma model. J Immunol 180 (2008) 1792-1799
9. Smits H.H., Hammad H., van N.M., Soullie T., Willart M.A., Lievers E., et al. Protective effect of Schistosoma mansoni infection on allergic airway inflammation depends on the intensity and chronicity of infection. J Allergy Clin Immunol 120 (2007) 932-940
10. Yang J., Zhao J., Yang Y., Zhang L., Yang X., Zhu X., et al. Schistosoma japonicum egg antigens stimulate CD4 CD25 T cells and modulate airway inflammation in a murine model of asthma. Immunology 120 (2007) 8-18
11. Trujillo-Vargas C.M., Werner-Klein M., Wohlleben G., Polte T., Hansen G., Ehlers S., et al. Helminth-derived products inhibit the development of allergic responses in mice. Am J Respir Crit Care Med 175 (2007) 336-344
12. Kitagaki K., Businga T.R., Racila D., Elliott D.E., Weinstock J.V., and Kline J.N. Intestinal helminths protect in a murine model of asthma. J Immunol 177 (2006) 1628-1635
13. Mangan N.E., Van R.N., McKenzie A.N., and Fallon P.G. Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness. J Immunol 176 (2006) 138-147
14. Wilson M.S., Taylor M.D., Balic A., Finney C.A., Lamb J.R., and Maizels R.M. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med 202 (2005) 1199-1212
15. Wohlleben G., Trujillo C., Muller J., Ritze Y., Grunewald S., Tatsch U., et al. Helminth infection modulates the development of allergen-induced airway inflammation. Int Immunol 16 (2004) 585-596
16. Mangan N.E., Fallon R.E., Smith P., Van R.N., McKenzie A.N., and Fallon P.G. Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J Immunol 173 (2004) 6346-6356
17. Wang C.C., Nolan T.J., Schad G.A., and Abraham D. Infection of mice with the helminth Strongyloides stercoralis suppresses pulmonary allergic responses to ovalbumin. Clin Exp Allergy 31 (2001) 495-503
18. Turner K.J., Shannahan K., and Holt P.G. Suppression of allergic reactivity by intestinal helminths: susceptibility is a function of IgE responder phenotype. Int Arch Allergy Appl Immunol 78 (1985) 329-331
19. Bashir M.E., Andersen P., Fuss I.J., Shi H.N., and Nagler-Anderson C. An enteric helminth infection protects against an allergic response to dietary antigen. J Immunol 169 (2002) 3284-3292
20. Nagler-Anderson C. Helminth-induced immunoregulation of an allergic response to food. Chem Immunol Allergy 90 (2006) 1-13
21. Ndiaye M., and Bousquet J. Allergies and parasitoses in sub-Saharan Africa. Clin Rev Allergy Immunol 26 (2004) 105-113
22. Wickelgren I. Immunotherapy: can worms tame the immune system?. Science 305 (2004) 170-171
23. Schubert C. The worm has turned. Nat Med 10 (2004) 1271-1272
24. Wilson M.S., and Maizels R.M. Regulation of allergy and autoimmunity in helminth infection. Clin Rev Allergy Immunol 26 (2004) 35-50
25. Jackson J.A., Friberg I.M., Little S., and Bradley J.E. Review series on helminths, immune modulation and the hygiene hypothesis: immunity against helminths and immunological phenomena in modern human populations: coevolutionary legacies?. Immunology 126 (2009) 18-27
26. Maizels R.M., and Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 3 (2003) 733-744
27. Cooper P.J., Chico M.E., Bland M., Griffin G.E., and Nutman T.B. Allergic symptoms, atopy, and geohelminth infections in a rural area of Ecuador. Am J Respir Crit Care Med 168 (2003) 313-317
28. Cooper P.J., Chico M.E., Rodrigues L.C., Ordonez M., Strachan D., Griffin G.E., et al. Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics. J Allergy Clin Immunol 111 (2003) 995-1000
29. Rodrigues L.C., Newcombe P.J., Cunha S.S., Cantara-Neves N.M., Genser B., Cruz A.A., et al. Early infection with Trichuris trichiura and allergen skin test reactivity in later childhood. Clin Exp Allergy 39 (2008) 1769-1777
30. Leonardi-Bee J., Pritchard D., and Britton J. Asthma and current intestinal parasite infection: systematic review and meta-analysis. Am J Respir Crit Care Med 174 (2006) 514-523
31. Flohr C., Quinnell R.J., and Britton J. Do helminth parasites protect against atopy and allergic disease?. Clin Exp Allergy 39 (2009) 20-32
32. Lynch N.R., Hagel I., Perez M., Di Prisco M.C., Lopez R., and Alvarez N. Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J Allergy Clin Immunol 92 (1993) 404-411
33. van den Biggelaar A.H., Rodrigues L.C., van R.R., van der Zee J.S., Hoeksma-Kruize Y.C., Souverijn J.H., et al. Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J Infect Dis 189 (2004) 892-900
34. Flohr C., Tuyen L.N., Lewis S., Minh T.T., Campbell J., Britton J., et al. Low efficacy of mebendazole against hookworm in Vietnam: two randomized controlled trials. Am J Trop Med Hyg 76 (2007) 732-736
35. Cooper P.J., Chico M.E., Vaca M.G., Moncayo A.L., Bland J.M., Mafla E., et al. Effect of albendazole treatments on the prevalence of atopy in children living in communities endemic for geohelminth parasites: a cluster-randomised trial. Lancet 367 (2006) 1598-1603
36. Oliveira R.R., Gollob K.J., Figueiredo J.P., Alcantara L.M., Cardoso L.S., Aquino C.S., et al. Schistosoma mansoni infection alters co-stimulatory molecule expression and cell activation in asthma. Microbes Infect 11 (2009) 223-229
37. Medeiros Jr. M., Almeida M.C., Figueiredo J.P., Atta A.M., Mendes C.M., Araujo M.I., et al. Low frequency of positive skin tests in asthmatic patients infected with Schistosoma mansoni exposed to high levels of mite allergens. Pediatr Allergy Immunol 15 (2004) 142-147
38. Medeiros Jr. M., Figueiredo J.P., Almeida M.C., Matos M.A., Araujo M.I., Cruz A.A., et al. Schistosoma mansoni infection is associated with a reduced course of asthma. J Allergy Clin Immunol 111 (2003) 947-951
39. Summers R.W., Elliott D.E., Qadir K., Urban Jr. J.F., Thompson R., and Weinstock J.V. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol 98 (2003) 2034-2041
40. Summers R.W., Elliott D.E., Urban Jr. J.F., Thompson R.A., and Weinstock J.V. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128 (2005) 825-832
41. Summers R.W., Elliott D.E., Urban Jr. J.F., Thompson R., and Weinstock J.V. Trichuris suis therapy in Crohn's disease. Gut 54 (2005) 87-90
42. Elliott D.E., Li J., Blum A., Metwali A., Qadir K., Urban Jr. J.F., et al. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 284 (2003) G385-G391
43. Elliott D.E., Setiawan T., Metwali A., Blum A., Urban Jr. J.F., and Weinstock J.V. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 34 (2004) 2690-2698
44. Weinstock J.V., Summers R.W., and Elliott D.E. Role of helminths in regulating mucosal inflammation. Springer Semin Immunopathol 27 (2005) 249-271
45. Wilson M.S., and Maizels R.M. Regulatory T cells induced by parasites and the modulation of allergic responses. Chem Immunol Allergy 90 (2006) 176-195
46. Burastero S.E., Mistrello G., Falagiani P., Paolucci C., Breda D., Roncarolo D., et al. Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production. Ann Allergy Asthma Immunol 100 (2008) 343-350
47. Radulovic S., Jacobson M.R., Durham S.R., and Nouri-Aria K.T. Grass pollen immunotherapy induces Foxp3-expressing CD4 + CD25+ cells in the nasal mucosa. J Allergy Clin Immunol 121 (2008) 1467-1472 1472.el
48. Francis J.N., Till S.J., and Durham S.R. Induction of IL-10 + CD4 + CD25 + T cells by grass pollen immunotherapy. J Allergy Clin Immunol 111 (2003) 1255-1261
49. Committee for Medicinal Products for Human Use, European Medicines Agency. Guideline on the clinical development of medicinal products for the treatment of allergic rhinoconjunctivitis. 2004. Available at: www.emea.europa.eu/pdfs/human/ewp/245502en.pdf. Accessed September 2009.
50. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Seoul, Korea, October 2008. Available at: http://www.wma.net/e/policy/b3.htm. September 2009.
51. Dahl R., Stender A., and Rak S. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy 61 (2006) 185-190
52. Dahl R., Kapp A., Colombo G., de Monchy J.G., Rak S., Emminger W., et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 118 (2006) 434-440
53. Kringel H., and Roepstorff A. Trichuris suis excretory/secretory antigen-specific antibodies in serum from single-inoculated pigs. Parasite Immunol 29 (2007) 327-330
54. Stahl Skov P., Norn S., and Weeke B. A new method for detecting histamine release. Agents Actions 14 (1984) 414-416
55. Beer R.J. Morphological descriptions of the egg and larval stages of Trichuris suis Schrank, 1788. Parasitology 67 (1973) 263-278
56. Beer R.J. Studies on the biology of the life-cycle of Trichuris suis Schrank, 1788. Parasitology 67 (1973) 253-262
57. Summers R.W., Elliott D.E., and Weinstock J.V. Why Trichuris suis should prove safe for use in inflammatory bowel diseases. Inflamm Bowel Dis 11 (2005) 783-784
58. Weinstock J.V., and Elliott D.E. Helminths and the IBD hygiene hypothesis. Inflamm Bowel Dis 15 (2009) 128-133
59. Akdis C.A., and Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 123 (2009) 735-746
60. Mortimer K., Brown A., Feary J., Jagger C., Lewis S., Antoniak M., et al. Dose-ranging study for trials of therapeutic infection with Necator americanus in humans. Am J Trop Med Hyg 75 (2006) 914-920
61. Croese J., O'Neil J., Masson J., Cooke S., Melrose W., Pritchard D., et al. A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors. Gut 55 (2006) 136-137
62. Bousquet J., Van C.P., and Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108 suppl 5 (2001) S147-S334